These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8541954)

  • 1. Chronic hepatitis in children.
    Maggiore G
    Curr Opin Pediatr; 1995 Oct; 7(5):539-46. PubMed ID: 8541954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic hepatitis B. Treatment in childhood with alpha-interferon].
    Wirth S; Sokal E; Schaefer E; Pohlenz J; Keller KM
    Monatsschr Kinderheilkd; 1992 Oct; 140(10):775-9. PubMed ID: 1435800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N
    J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the basic core promotor and the precore region of hepatitis B virus and their selection in children with fulminant and chronic hepatitis B.
    Friedt M; Gerner P; Lausch E; Trübel H; Zabel B; Wirth S
    Hepatology; 1999 Apr; 29(4):1252-8. PubMed ID: 10094972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on prevention and treatment of viral hepatitis in children.
    Sokal EM; Bortolotti F
    Curr Opin Pediatr; 1999 Oct; 11(5):384-9. PubMed ID: 10555588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
    Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic active hepatitis and related disorders.
    Larcher V
    Clin Gastroenterol; 1986 Jan; 15(1):173-98. PubMed ID: 3082542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis.
    Lambiase L; Davis GL
    Gastroenterol Clin North Am; 1992 Sep; 21(3):659-77. PubMed ID: 1381338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current issues in the management of paediatric viral hepatitis.
    Yeung LT; Roberts EA
    Liver Int; 2010 Jan; 30(1):5-18. PubMed ID: 19840256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vertically acquired hepatitis C virus infection: Correlates of transmission and disease progression.
    Tovo PA; Calitri C; Scolfaro C; Gabiano C; Garazzino S
    World J Gastroenterol; 2016 Jan; 22(4):1382-92. PubMed ID: 26819507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic viral hepatitis in childhood.
    Bortolotti F
    Baillieres Clin Gastroenterol; 1996 Jul; 10(2):185-206. PubMed ID: 8864029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for chronic viral hepatitis.
    Alvarez F
    Clin Invest Med; 1996 Oct; 19(5):381-8. PubMed ID: 8889278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B e antigen-negative chronic hepatitis B patients: spontaneous seroconversion and interferon-induced seroconversion.
    Karasawa T; Aizawa Y; Zeniya M; Kuramoto A; Shirasawa T; Toda G
    J Med Virol; 1995 Apr; 45(4):373-80. PubMed ID: 7666040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.
    Utili R; Sagnelli E; Gaeta GB; Galanti B; Nardiello S; Felaco FM; Pasquale G; Marrone A; Aprea L; Pizzella T
    J Hepatol; 1994 Feb; 20(2):163-7. PubMed ID: 8006395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection.
    Marinos G; Torre F; Günther S; Thomas MG; Will H; Williams R; Naoumov NV
    Gastroenterology; 1996 Jul; 111(1):183-92. PubMed ID: 8698197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the predominant hepatitis B virus precore variants in hepatitis B e antigen-positive children and their effect on treatment response.
    Cabrerizo M; Bartolomé J; Ruiz-Moreno M; Otero M; López-Alcorocho JM; Carreño V
    Pediatr Res; 1996 Jun; 39(6):980-4. PubMed ID: 8725258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection.
    Marinos G; Naoumov NV; Rossol S; Torre F; Wong PY; Gallati H; Portmann B; Williams R
    Gastroenterology; 1995 May; 108(5):1453-63. PubMed ID: 7729638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of chronic hepatitis B in adolescents or young adults in follow-up from childhood.
    Fujisawa T; Komatsu H; Inui A; Sogo T; Miyagawa Y; Fujitsuka S; Sekine I; Kosugi T; Inui M
    J Pediatr Gastroenterol Nutr; 2000 Feb; 30(2):201-6. PubMed ID: 10697141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.